Parker Waichman LLP

FDA Panel Wants Restrictions on Two Asthma Drugs

A U.S. Food and Drug Administration (FDA) panel has called for restrictions on two asthma treatments:  Serevent and Foradil.  Both belong to a class  of drugs known as long-acting beta-agonists.  Both contain a drug that relaxes muscles around airways, said WHEC TV, but may also mask symptoms that can prompt deadly asthma attacks.  Although the […]

A U.S. Food and Drug Administration (FDA) panel has called for restrictions on two asthma treatments:  <"https://www.yourlawyer.com/topics/overview/serevent">Serevent and <"https://www.yourlawyer.com/topics/overview/Foradil">Foradil.  Both belong to a class  of drugs known as long-acting beta-agonists.  Both contain a drug that relaxes muscles around airways, said WHEC TV, but may also mask symptoms that can prompt deadly asthma attacks.  Although the expert 27-member panel found Serevent and Foradil drugs present greater risks than benefits and should not be used in the treatment of asthma, the inhaler drugs will likely not be pulled, said WebMD Health News.

The panel suggested the FDA alert physicians to not prescribe Serevent and Foradil as a stand-alone treatment for patients of any age, said WebMD; however, the drugs’ use in chronic obstructive pulmonary disease (COPD) remains unaffected.  The panel backed Symbicort and Advair, finding the benefits were greater than the risks, added WebMD.

NBC noted that with 20 million Americans suffering from asthma, it is critical they receive appropriate treatment at the first sign of an attack, noting that the panel was reviewing the benefits and risks—such as hospitalization and death—of a variety of asthma medications.

NBC pointed out that Advair, Serevent, Foradil, and Symbicort are all long-lasting medications that might reduce reliance on rescue inhalers.  But, an FDA study found that long-lasting drugs present a two-to-seven times greater risk over other medications for severe complications and death, especially in women, African-Americans, and children under 12. Doctors recommend, said NBC, that these drugs be used in collaboration with inhaled cortico-steroids, which treat inflammation.   In Symbicort and Advair, the steroid is built in.  Advair was the only one of the four drugs with no increased risk, reported NBC.

Angel Waldron of the Asthma and Allergy Foundation of America told NBC that, “Removing them or limiting access to them would be setting us back about fifteen years in asthma care,“ but not all experts agreed.  One recommended Serevent and Foradil be pulled and all four banned for children.  Another felt the benefits “far outweighed” the risks, said NBC, which noted of 60,000 patients studied, 20 suffered asthma-related deaths.

Medical guidelines and the drugs’ labeling recommend long-acting beta-agonists only be used with inhaled steroids to minimize airway inflammation; the combination lowers risks to levels experts find acceptable, reported WebMD Health News.  But studies reveal most asthma patients tend not to use inhaled steroids as prescribed when taking them separately from beta-agonists and patients receive relief from beta-agonist inhalers, leading many to use them alone—a practice called monotherapy—which raises the drugs’ risks, according to the FDA studies, said Web MD.

“I think the label should be greatly strengthened to say that monotherapy for asthma should basically be contraindicated” for Serevent and Foradil, Daniel Notterman, MD, a member of the advisory panel from the department of molecular biology at Princeton University, told Web MD Health News.

Notterman was not alone, and the FDA panel agreed with him in a 17-to-10 vote, saying Serevent and Foradil’s risks outweigh benefits when used alone.  The panel found voted unanimously that neither drug be used in younger children four to 11 years old, said Web MD Health News.

“The data is that single use is dangerous,” David Schoenfeld, PhD, a panelist and professor of medicine from Massachusetts General Hospital, told Web MD.

Because Advair contains both a beta-agonist and steroids, thus reducing the risk of airway passage inflammation,  the pane backed that drug.  However, there was disagreement among panel members regarding Advair’s use in children.  The fourth drug, Symbicort, is not generally prescribed for children said Web MD.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Excellent law firm. Thank you Parker Waichman on behalf of my father Eucebio Concepcion for helping us with his worker’s compensation case. It was a great experience, they explained the the process step by step. Thank you so much to Jorge Peniche for being super patient with us!!
Leanna Erazo
4 years ago
5 Star Reviews 150
You guys are the best lawyer institutions i have ever know thank you for helping me so much with my case ❤️
estarlin torres
9 months ago
5 Star Reviews 150
I would just like to say that Joanne Stevens and Parker Waichman are doing a great job in handling my case. Very happy with the work being done.
Steve Fisher
5 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038